Good progress on both fronts IMO. Indicating potassium and kidney disease for the biochip brings a real sense of reality and purpose. My understanding of the 12cq is vague despite reading up the info (Tks Geeris for the updates) but the progress is welcome and hopefully soon they do offer potential uses / targets for use. I’m comfortable the spend seems well under control. I would hope they would get some more government funding if required but at this stage significant funds might come from venture capitalist / strategic investor. Super funds and brokers might be a way off?? Of course a strategic partnership would be awesome - chip company, google, apple, IBM, Defence Dept?? Who knows but a decent risk play at these levels.
AXE Price at posting:
24.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)